BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 24073955)

  • 1. [Cold agglutinin disease -  no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature].
    Adam Z; Pejchalová A; Chlupová G; Ríhová L; Pour L; Krejčí M; Cervinek L; Král Z; Mayer J
    Vnitr Lek; 2013 Sep; 59(9):828-40. PubMed ID: 24073955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of the thermal amplitude after rituximab treatment for cold agglutinin disease with Waldenström's macroglobulinemia.
    Hattori N; Ishii N; Ariizumi H; Adachi D; Matsuda I; Nakamaki T; Tomoyasu S
    Ann Hematol; 2010 Jan; 89(1):103-4. PubMed ID: 19513714
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of cold haemolytic syndrome.
    Gertz MA
    Br J Haematol; 2007 Aug; 138(4):422-9. PubMed ID: 17561970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of autoimmune haemolytic anaemia achieving complete response with rituximab.
    Dev M; Mushtaq N; Faisal A
    J Pak Med Assoc; 2014 Jun; 64(6):700-2. PubMed ID: 25252495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia.
    Glaser M; Glaser A; Skalicky M
    Wien Klin Wochenschr; 2011 Nov; 123(21-22):680-3. PubMed ID: 21947363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delayed response to rituximab of cold agglutinin haemolytic disease].
    Calvo-Villas JM; Cuesta Tovar J; Carreter de Granda E; Sicilia Guillén F
    An Med Interna; 2006 May; 23(5):224-8. PubMed ID: 16817700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune haemolytic anaemia: a review and report of four cases].
    Nyilas R; Székely B; Váróczy L; Simon Z; Árokszállási A; Illés Á; Gergely L
    Orv Hetil; 2015 Mar; 156(11):449-56. PubMed ID: 25749539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of rituximab in combination with oral cyclophosphamide in primary chronic cold agglutinin disease.
    Vassou A; Alymara V; Chaidos A; Bourantas KL
    Int J Hematol; 2005 Jun; 81(5):421-3. PubMed ID: 16158824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy.
    Tanaka H; Hashimoto S; Sugita Y; Sakai S; Takeda Y; Abe D; Takagi T; Nakaseko C
    Int J Hematol; 2012 Oct; 96(4):501-5. PubMed ID: 22878940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacity of rituximab in hemolytic anemia with cold autoantibodies case].
    Sekkach Y; Hammi S; Elqatni M; Fatihi J; Elomri N; Mekouar F; Badaoui M; Jira M; Smaali J; El Khattabi A; Amezyane T; Abouzahir A; Ghafir D
    Ann Pharm Fr; 2011 Jul; 69(4):205-8. PubMed ID: 21840439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenström's macroglobulinemia.
    Berentsen S
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):110-2. PubMed ID: 19362990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in the treatment of autoimmune haemolytic anaemia.
    Rodrigo C; Rajapakse S; Gooneratne L
    Br J Clin Pharmacol; 2015 May; 79(5):709-19. PubMed ID: 25139610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG-mediated haemolysis masquerading as cold agglutinin-induced anaemia complicating severe infection with mycoplasma pneumoniae.
    Louie EK; Ault KA; Smith BR; Hardman EL; Quesenberry PJ
    Scand J Haematol; 1985 Sep; 35(3):264-9. PubMed ID: 3933104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I manage patients with cold agglutinin disease.
    Berentsen S
    Br J Haematol; 2018 May; 181(3):320-330. PubMed ID: 29363757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monotherapy with rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma.
    Cohen Y; Polliack A; Zelig O; Goldfarb A
    Leuk Lymphoma; 2001; 42(6):1405-8. PubMed ID: 11911426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia.
    Gertz MA
    Hematol Oncol Clin North Am; 2022 Apr; 36(2):341-352. PubMed ID: 35282954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rituximab in cold agglutinin disease].
    Camou F; Viallard JF; Pellegrin JL
    Rev Med Interne; 2003 Aug; 24(8):501-4. PubMed ID: 12888170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
    Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
    Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.
    Valent P; Lechner K
    Wien Klin Wochenschr; 2008; 120(5-6):136-51. PubMed ID: 18365153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
    Ono K; Sato T; Iyama S; Tatekoshi A; Hashimoto A; Kamihara Y; Horiguchi H; Kikuchi S; Takada K; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
    Rinsho Ketsueki; 2013 Nov; 54(11):2053-5. PubMed ID: 24305538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.